Stocks and Investing
Stocks and Investing
Mon, September 25, 2017
[ Mon, Sep 25th 2017
] - WOPRAI
[ Mon, Sep 25th 2017
] - WOPRAI
[ Mon, Sep 25th 2017
] - WOPRAI
[ Mon, Sep 25th 2017
] - WOPRAI
[ Mon, Sep 25th 2017
] - WOPRAI
[ Mon, Sep 25th 2017
] - WOPRAI
[ Mon, Sep 25th 2017
] - WOPRAI
[ Mon, Sep 25th 2017
] - WOPRAI
[ Mon, Sep 25th 2017
] - WOPRAI
Fri, September 22, 2017
[ Fri, Sep 22nd 2017
] - WOPRAI
[ Fri, Sep 22nd 2017
] - WOPRAI
[ Fri, Sep 22nd 2017
] - WOPRAI
[ Fri, Sep 22nd 2017
] - WOPRAI
[ Fri, Sep 22nd 2017
] - WOPRAI
[ Fri, Sep 22nd 2017
] - WOPRAI
[ Fri, Sep 22nd 2017
] - WOPRAI
[ Fri, Sep 22nd 2017
] - WOPRAI
[ Fri, Sep 22nd 2017
] - WOPRAI
[ Fri, Sep 22nd 2017
] - WOPRAI
[ Fri, Sep 22nd 2017
] - WOPRAI
Alethia Young Maintained (ASND) at Buy with Increased Target to $50 on, Sep 22nd, 2017
Alethia Young of Credit Suisse, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $30 to $50 on, Sep 22nd, 2017.
Alethia, nor any peers, have made any analyst calls on ASND in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources
Similar Stocks and Investing Articles
[ Thu, May 11th 2017
] - WOPRAI
[ Fri, Mar 24th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Dec 22nd 2016
] - WOPRAI
[ Fri, Sep 30th 2016
] - WOPRAI
[ Thu, Sep 29th 2016
] - WOPRAI
[ Thu, Sep 22nd 2016
] - WOPRAI
[ Mon, Jun 13th 2016
] - WOPRAI
[ Mon, Jun 13th 2016
] - WOPRAI